Cryptococcus neoformans

Results: 74



#Item
31EDITORIAL Phased implementation of screening for cryptococcal disease in South Africa Cryptococcus neoformans is the most common cause of laboratoryconfirmed meningitis in South Africa.1 Despite the increased coverage of

EDITORIAL Phased implementation of screening for cryptococcal disease in South Africa Cryptococcus neoformans is the most common cause of laboratoryconfirmed meningitis in South Africa.1 Despite the increased coverage of

Add to Reading List

Source URL: preventcrypto.org

Language: English - Date: 2012-12-08 13:59:40
32EDITORIAL Phased implementation of screening for cryptococcal disease in South Africa Cryptococcus neoformans is the most common cause of laboratoryconfirmed meningitis in South Africa.1 Despite the increased coverage of

EDITORIAL Phased implementation of screening for cryptococcal disease in South Africa Cryptococcus neoformans is the most common cause of laboratoryconfirmed meningitis in South Africa.1 Despite the increased coverage of

Add to Reading List

Source URL: preventcrypto.org

Language: English - Date: 2012-12-19 14:23:17
33JAIDS Journal of Acquired Immune Deficiency Syndromes Publish Ahead of Print DOI: [removed]QAI.0b013e3182926f95 Prevalence and Outcomes of Cryptococcal Antigenemia in HIV-seropositive Patients Hospitalized for Suspected T

JAIDS Journal of Acquired Immune Deficiency Syndromes Publish Ahead of Print DOI: [removed]QAI.0b013e3182926f95 Prevalence and Outcomes of Cryptococcal Antigenemia in HIV-seropositive Patients Hospitalized for Suspected T

Add to Reading List

Source URL: preventcrypto.org

Language: English - Date: 2013-04-16 16:30:09
34Poster Abstract Session: 187. Clinical Practice Issues Saturday, October 20th 2012: 12:30 p.m. – 2:00 p.m. #1375. Fluconazole resistance in cryptococcus neoformans: an emerging threat to the immune-compromised

Poster Abstract Session: 187. Clinical Practice Issues Saturday, October 20th 2012: 12:30 p.m. – 2:00 p.m. #1375. Fluconazole resistance in cryptococcus neoformans: an emerging threat to the immune-compromised

Add to Reading List

Source URL: preventcrypto.org

Language: English - Date: 2012-11-14 21:33:31
35Jessica Hansen, E. Susan Slechta, Marcellene A. Gates-Hollingsworth, Brandon Neary, Adam P. Barker, Sean Bauman, Thomas R. Kozel and Kimberly E. Hanson Clin. Vaccine Immunol. 2013, 20(1):52. DOI: [removed]CVI[removed]Pu

Jessica Hansen, E. Susan Slechta, Marcellene A. Gates-Hollingsworth, Brandon Neary, Adam P. Barker, Sean Bauman, Thomas R. Kozel and Kimberly E. Hanson Clin. Vaccine Immunol. 2013, 20(1):52. DOI: [removed]CVI[removed]Pu

Add to Reading List

Source URL: preventcrypto.org

Language: English - Date: 2013-01-26 12:05:52
36Prevalence of Fluconazole Resistance in Cryptococcus neoformans Isolates from HIV+ Patients in Kampala, Uganda Beatrice Achan*1, D Boulware2, D Meya1,2,3, K Nielsen2, and Cryptococcal Optimal ART Timing Trial 1

Prevalence of Fluconazole Resistance in Cryptococcus neoformans Isolates from HIV+ Patients in Kampala, Uganda Beatrice Achan*1, D Boulware2, D Meya1,2,3, K Nielsen2, and Cryptococcal Optimal ART Timing Trial 1

Add to Reading List

Source URL: preventcrypto.org

Language: English - Date: 2013-03-08 00:34:20
37Jessica Hansen, E. Susan Slechta, Marcellene A. Gates-Hollingsworth, Brandon Neary, Adam P. Barker, Sean Bauman, Thomas R. Kozel and Kimberly E. Hanson Clin. Vaccine Immunol. 2013, 20(1):52. DOI: [removed]CVI[removed]Pu

Jessica Hansen, E. Susan Slechta, Marcellene A. Gates-Hollingsworth, Brandon Neary, Adam P. Barker, Sean Bauman, Thomas R. Kozel and Kimberly E. Hanson Clin. Vaccine Immunol. 2013, 20(1):52. DOI: [removed]CVI[removed]Pu

Add to Reading List

Source URL: preventcrypto.org

Language: English - Date: 2013-01-26 11:10:21
38The  n e w e ng l a n d j o u r na l of

The n e w e ng l a n d j o u r na l of

Add to Reading List

Source URL: preventcrypto.org

Language: English - Date: 2013-06-02 08:53:44
39Clinical Utility of the Cryptococcal Antigen Lateral Flow Assay in a Diagnostic Mycology Laboratory Brendan J. McMullan1,2*., Catriona Halliday1., Tania C. Sorrell3,4, David Judd1, Sue Sleiman1, Debbie Marriott5, Tom Olm

Clinical Utility of the Cryptococcal Antigen Lateral Flow Assay in a Diagnostic Mycology Laboratory Brendan J. McMullan1,2*., Catriona Halliday1., Tania C. Sorrell3,4, David Judd1, Sue Sleiman1, Debbie Marriott5, Tom Olm

Add to Reading List

Source URL: preventcrypto.org

Language: English - Date: 2013-01-26 11:59:39
40Cryptococcal Meningitis Treatment Strategies in Resource-Limited Settings: A Cost-Effectiveness Analysis Radha Rajasingham1,2, Melissa A. Rolfes2, Kate E. Birkenkamp2, David B. Meya1,2, David R. Boulware2* 1 Infectious D

Cryptococcal Meningitis Treatment Strategies in Resource-Limited Settings: A Cost-Effectiveness Analysis Radha Rajasingham1,2, Melissa A. Rolfes2, Kate E. Birkenkamp2, David B. Meya1,2, David R. Boulware2* 1 Infectious D

Add to Reading List

Source URL: preventcrypto.org

Language: English - Date: 2013-06-17 15:42:56